4/12/2012 - Rachel Tyndale, Ph.D., a leading pharmacogeneticist at the University of Toronto, will give the 8th annual Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Tuesday, April 17.
Tyndale's lecture, entitled “Pharmacogenetics: The Making and Unmaking of a Smoker,” will begin at 8:30 a.m. in 208 Light Hall. A reception in 208 Light Hall will precede the lecture at 8 a.m.
Tyndale is professor of Psychiatry, Pharmacology and Toxicology at the University of Toronto, and Canada Research Chair in Pharmacogenetics. She also is head of Pharmacogenetics at the Centre for Addiction and Mental Health, Canada's largest mental health and addiction teaching hospital.
Her research group focuses on pharmacogenetic variation in enzymes and drug targets, and the resulting impact on drug dependence, particularly smoking.
Tyndale received her Ph.D. in Pharmacology from the University of Toronto, and was a postdoctoral fellow at the University of California, Los Angeles. She is a member of several editorial and scientific advisory boards, and has received numerous awards for her work.
The endowed Wilkinson lectureship was established in 2005 to honor Vanderbilt clinical pharmacologist and professor of Pharmacology, emeritus, Grant Wilkinson, Ph.D., D.Sc., who died in 2006.
Tyndale's lecture is sponsored by the Division of Clinical Pharmacology, the Department of Pharmacology and Vanderbilt University School of Medicine.©2013 Vanderbilt University Medical Center